文献速递前列腺癌

微超声经验与临床显著前列腺癌检出:OPTIMUM随机试验的中心层面分析

Micro-ultrasound experience and clinically significant prostate cancer detection: a center-level analysis of the optimum randomized trial.
PubMed 文献 · Prostate Cancer Prostatic Dis · 2026-10-28

基于多中心随机OPTIMUM试验数据,采用两种逻辑回归模型预测临床显著前列腺癌(csPCa)。中心层面经验代理指标未改善csPCa检出区分度,两模型AUC均为0.803;csPCa与年龄增长、PSA升高、前列腺体积较小、DRE可疑显著相关,低PRI-MUS评分(1-2)与csPCa风险降低相关。

要点

  • 中心层面经验代理指标未改善csPCa检出区分度。
  • csPCa与年龄、PSA、前列腺体积、DRE及PRI-MUS评分相关。
  • 确保操作者达到Level 3熟练度可能减少学习曲线影响。

核心结论

  • 在确保所有参与操作者达到Level 3熟练度并纳入经验代理指标与临床危险因素及PRI-MUS评分后,中心层面经验与csPCa检出无关。

研究设计与样本

  • 多中心随机OPTIMUM试验数据分析,使用两种逻辑回归模型预测csPCa,中心层面经验由Center Case Load Score和Center Mastery Score两种标准化测量表示。

主要发现

  • 经验代理指标未改善csPCa检出的区分度,模型1与模型2的敏感度/特异度/AUC分别为0.851/0.523/0.803与0.851/0.544/0.803。
  • 模型1中经验代理指标不是显著预测因子;csPCa与年龄增长(p < 0.001)、PSA升高(p < 0.001)、前列腺体积较小(p < 0.001)、DRE可疑(p = 0.001)显著相关。
  • 低PRI-MUS评分(1-2)与csPCa风险降低相关(p = 0.001)。

临床怎么用

  • 在微超声引导前列腺活检中,确保操作者达到Level 3熟练度可能有助于减少学习曲线对csPCa检出的影响。

局限性

  • 操作者异质性和经验代理指标的潜在偏倚仍是局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Micro-ultrasound real-time imaging technology is increasingly performed for prostate biopsy. While a learning curve is expected, the effect of operator experience on clinically significant prostate cancer (csPCa) detection has not been clearly defined. METHODS: We analyzed data from the multicenter randomized OPTIMUM trial utilizing two logistic regression models to predict csPCa. Center-level experience was represented by two standardized measures derived from operator-level data: Center Case Load Score and Center Mastery Score. Model 1 included the Center Mastery Score and Center Case Volume; Model 2 excluded them. Performance was assessed using confusion matrices and the area under the curve (AUC). RESULTS: Experience proxies did not improve discrimination for csPCa detection. Sensitivity/specificity/AUC were 0.851/0.523/0.803 vs 0.851/0.544/0.803 for Models 1 and 2, respectively. In Model 1, experience proxies were not significant predictors; csPCa was significantly associated with increasing age (p < 0.001), higher PSA (p < 0.001), smaller prostate volume (p < 0.001), suspicious DRE (p = 0.001). Low PRI-MUS Score (1-2) was associated with decreased risk of csPCa (p = 0.001). Operator heterogeneity and potential bias in experience proxies remain limitations. CONCLUSION: Ensuring Level 3 proficiency among all participating operators and incorporating experience proxies with clinical risk factors and PRI-MUS score, center-level experience was not associated with csPCa detection. Our results reflect the successful integration of proficiency standards in clinical practice, while minimizing learning curve effects, and suggest that the required proficiency threshold was an effective proxy for mastery of microUS.

来源:Prostate Cancer Prostatic Dis,查看原文。版权归原作者所有。

引用

  1. Guer, Lazarovich, Luger, et al. Micro-ultrasound experience and clinically significant prostate cancer detection: a center-level analysis of the optimum randomized trial. Prostate Cancer Prostatic Dis. 2026. PMID: 42957822. doi:10.1038/s41391-026-01171-y

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。